- Home
- TLS vs STRO Comparison
TLS vs STRO Comparison
Compare TLS & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLS
- STRO
- Stock Information
- Founded
- TLS 1969
- STRO 2003
- Country
- TLS United States
- STRO United States
- Employees
- TLS N/A
- STRO N/A
- Industry
- TLS EDP Services
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TLS Technology
- STRO Health Care
- Exchange
- TLS Nasdaq
- STRO Nasdaq
- Market Cap
- TLS 238.1M
- STRO 292.6M
- IPO Year
- TLS 2020
- STRO 2018
- Fundamental
- Price
- TLS $3.37
- STRO $2.84
- Analyst Decision
- TLS Buy
- STRO Strong Buy
- Analyst Count
- TLS 6
- STRO 7
- Target Price
- TLS $4.80
- STRO $12.14
- AVG Volume (30 Days)
- TLS 782.1K
- STRO 1.0M
- Earning Date
- TLS 11-12-2024
- STRO 11-13-2024
- Dividend Yield
- TLS N/A
- STRO N/A
- EPS Growth
- TLS N/A
- STRO N/A
- EPS
- TLS N/A
- STRO N/A
- Revenue
- TLS $122,959,000.00
- STRO $160,955,000.00
- Revenue This Year
- TLS N/A
- STRO N/A
- Revenue Next Year
- TLS $38.31
- STRO N/A
- P/E Ratio
- TLS N/A
- STRO N/A
- Revenue Growth
- TLS N/A
- STRO 230.90
- 52 Week Low
- TLS $1.89
- STRO $2.45
- 52 Week High
- TLS $5.03
- STRO $6.13
- Technical
- Relative Strength Index (RSI)
- TLS 42.03
- STRO 41.69
- Support Level
- TLS $3.10
- STRO $2.66
- Resistance Level
- TLS $3.46
- STRO $2.86
- Average True Range (ATR)
- TLS 0.15
- STRO 0.19
- MACD
- TLS -0.01
- STRO 0.02
- Stochastic Oscillator
- TLS 39.68
- STRO 78.00
About TLS Telos Corporation
Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.